van Zandvoort Kevin, Hassan Abdirahman Ibrahim, Bobe Mohamed Omer, Pell Casey L, Ahmed Mohamed Saed, Ortika Belinda D, Ibrahim Saed, Abdi Mohamed Ismail, Karim Mustapha A, Eggo Rosalind M, Ali Saleban Yousuf, Hinds Jason, Soleman Saeed Mohamood, Cummings Rachael, McGowan Catherine R, Mulholland E Kim, Hergeye Mohamed Abdi, Satzke Catherine, Checchi Francesco, Flasche Stefan
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Republic of Somaliland Ministry of Health Development, Hargeisa, Somaliland.
Pneumonia (Nathan). 2024 Dec 5;16(1):25. doi: 10.1186/s41479-024-00148-6.
Populations affected by humanitarian crises likely experience high burdens of pneumococcal disease. Streptococcus pneumoniae carriage estimates are essential to understand pneumococcal transmission dynamics and the potential impact of pneumococcal conjugate vaccines (PCV). Over 100 million people are forcibly displaced worldwide, yet here we present only the second pneumococcal carriage estimates for a displaced population.
In October 2019, we conducted a cross-sectional survey among internally displaced people (IDP) living in Digaale, a permanent IDP camp in Somaliland where PCV has not been implemented. We collected nasopharyngeal swab samples from 453 residents which were assessed for presence of pneumococci and serotyped using DNA microarray.
We found that pneumococcal carriage prevalence was 36% (95%CI 31-40) in all ages, and 70% (95%CI 64-76) in children under 5. The three most common serotypes were vaccine serotypes 6B, 19F, and 23F. We estimated that the serotypes included in the 10-valent PNEUMOSIL vaccine were carried by 41% (95%CI 33-49) of all pneumococcal carriers and extrapolated that they caused 52% (95%CI 35-70) of invasive pneumococcal disease. We found some evidence that pneumococcal carriage was associated with recent respiratory symptoms, the total number of physical contacts made, and with malnutrition in children under 5. Through linking with a nested contact survey we projected that pneumococcal exposure of children under 2 was predominantly due to contact with children aged 2-5 (39%; 95%CI 31-48) and 6-14 (25%; 95%CI 17-34).
These findings suggest considerable potential for direct and indirect protection against pneumococcal disease in Digaale through PCV use in children and potentially adolescents.
受人道主义危机影响的人群可能承受着肺炎球菌疾病的沉重负担。肺炎链球菌携带率的估计对于了解肺炎球菌传播动态以及肺炎球菌结合疫苗(PCV)的潜在影响至关重要。全球有超过1亿人被迫流离失所,但在此我们仅展示了针对流离失所人群的第二项肺炎球菌携带率估计。
2019年10月,我们在迪加尔(Digaale)的境内流离失所者(IDP)中进行了一项横断面调查,迪加尔是索马里兰的一个永久性境内流离失所者营地,尚未实施PCV。我们从453名居民中收集了鼻咽拭子样本,评估是否存在肺炎球菌,并使用DNA微阵列进行血清分型。
我们发现,所有年龄段的肺炎球菌携带率为36%(95%CI 31 - 40),5岁以下儿童为70%(95%CI 64 - 76)。三种最常见的血清型是疫苗血清型6B、19F和23F。我们估计,10价PNEUMOSIL疫苗中包含的血清型在所有肺炎球菌携带者中占41%(95%CI 33 - 49),并推断它们导致了52%(95%CI 35 - 70)的侵袭性肺炎球菌疾病。我们发现一些证据表明,肺炎球菌携带与近期呼吸道症状、身体接触总数以及5岁以下儿童的营养不良有关。通过与一项嵌套接触调查相联系,我们预计2岁以下儿童的肺炎球菌暴露主要是由于与2 - 5岁(39%;95%CI 31 - 48)和6 - 14岁(25%;95%CI 17 - 34)的儿童接触。
这些发现表明,在迪加尔,通过在儿童甚至可能在青少年中使用PCV,对肺炎球菌疾病进行直接和间接保护具有相当大的潜力。